Table 2.
Expression of B-cell-associated antigens in patients
| Flow cytometry markers |
B-CLL
(n = 91) |
Atypical B-CLL
(n = 15) |
MCL
(n = 14) |
CD5-/CD10-lymphoma (n = 11) |
p
value |
|---|---|---|---|---|---|
| CD19 | 76.3 ± 12.2 | 71.4 ± 13.4 | 69.3 ± 10.2 | 61.3 ± 15.2 | 0.1 |
| CD20 | 70.2 ± 14.2 | 74.3 ± 14.1 | 74.3 ± 12.5 | 77.4 ± 11.4 | 0.2 |
| CD22 | 18.4 ± 13.8 | 43.1 ± 17.9 | 65.2 ± 14.4 | 60.5 ± 10.1 | 0.000 |
| CD5 | 79.89 ± 13.2 | 45.5 ± 27.0 | 86.7 ± 9.6 | 12.5 ± 5.7 | 0.000 |
| CD23 | 66.7 ± 16.4 | 31.0 ± 22.8 | 8.2 ± 3.4 | 9.1 ± 6.7 | 0.000 |
| FMC-7 | 1.3 ± 2.3 | 12.5 ± 9.2 | 40.4 ± 9.6 | 27.7 ± 9.8 | 0.000 |
| CD38 | 2.5 ± 5.4 | 9.5 ± 8.7 | 65.9 ± 21.2 | 10.5 ± 5.3 | 0.000 |
Data are shown as mean percentage ± SD.